Background This is an update of the Cochrane Review published in Issue 4, 2015. Cervical
cancer is one of the most frequent cause of death from gynaecological cancers worldwide …

Backgrounds Concurrent chemo-radiotherapy in patients with locally advanced cervical
cancer has significant hematologic toxicities (HT), leading to treatment disruption and …

Human cervical cancer is the fourth most common malignancy among women worldwide,
and it is expected to result in 460,000 deaths per year by 2040. Moreover, patients with …

Background Novel therapies are needed to treat recurrent and advanced cervical cancer
(CC), as their prognosis remains very poor. Although therapies targeting the programmed …

Cervical cancer is among the most cancer types, with an extremely high global incidence
and mortality. Ferroptosis is a newly reported programmed cell death process that differs …

Based on many studies, trichosanthin (TCS) has an antiviral effect that regulates immune
response, and targets cancer cells to exert broad-spectrum anti-tumor pharmacological …

Objective. Cancer‐derived exosomes can facilitate drug resistance in cervical cancer.
However, the mechanisms remain elusive. Herein, we observed the roles of exosomal miR …

This study is to investigate the role of regulatory B (Breg) cells in cervical cancer. In total, 70
cases of cervical cancer, 52 cases of cervical intraepithelial neoplasia (CIN), and 40 normal …

Venous thromboembolism (VTE) is a leading cause of death among cancer patients.
Khorana score (KS) is the most studied tool to predict cancer-related VTE, however, it exerts …

Cervical cancer is a global health issue and places a considerable economic and medical
burden on society. Thus, a concerted effort to improve the treatment of cervical cancer is …